{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:40:28Z","timestamp":1793295628024,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.euros.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:29:09Z","timestamp":1789673349000},"page":"1-2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer \u2013 a nationwide register\u2011based study. Eur Urol Open Sci 2026;90:92\u2011100"],"prefix":"10.1016","volume":"93","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0062-7399","authenticated-orcid":false,"given":"Yapeng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.08.008_b0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.euros.2026.06.011","article-title":"Substaging and stratified treatment of T1 bladder cancer \u2013 a nationwide register-based study","volume":"90","author":"Nielsen","year":"2026","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.08.008_b0010","doi-asserted-by":"crossref","unstructured":"Gontero P, Mariappan P, Pradere B, et al. EAU guidelines on nonmuscle-invasive bladder cancer (TaT1 and CIS) \u2013 a summary of the 2026 guidelines update. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2026.04.009.","DOI":"10.1016\/j.eururo.2026.04.009"},{"key":"10.1016\/j.euros.2026.08.008_b0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.eururo.2026.01.008","article-title":"Active surveillance versus intravesical Bacillus Calmette\u2013Gu\u00e9rin for high-grade T1 bladder cancer with negative second transurethral resection: the randomized noninferiority phase 3 JCOG1019 trial","volume":"89","author":"Kitamura","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.08.008_b0020","first-page":"192","article-title":"Predicting response to intravesical Bacillus Calmette\u2013Gu\u00e9rin in high-risk nonmuscle-invasive bladder cancer using an artificial intelligence-powered pathology assay: development and validation in an international 12-center cohort","volume":"213","author":"Lotan","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.08.008_b0025","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326012826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326012826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:29:30Z","timestamp":1793294970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326012826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":5,"alternative-id":["S2666168326012826"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.08.008","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer \u2013 a nationwide register\u2011based study. Eur Urol Open Sci 2026;90:92\u2011100","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}